Desteklenen Projeler
1
-
2022 - Devam Ediyor A randomised, double-blind, parallel group, equivalence, multicenter phase III trial to compare the efficacy, safety, pharmacokinetics and immunogenicity of HD204 to Avastin® in patients with metastatic or recurrent non-squamous non-small cell lung cancer SAMSON II
Diğer Uluslararası Fon Programları
ÇAKIR PEKÖZ B., ÇİL T., Menteş Z., KESEN O., SÖKER G., BAYHAN A. Z., et al.